Scarica l'app Stockscreener
86.22
0.55%
0.47
Dopo l'orario di chiusura:
85.68
-0.54
-0.63%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$85.75
Aprire:
$85.88
Volume 24 ore:
252.82K
Relative Volume:
0.60
Capitalizzazione di mercato:
$3.00B
Reddito:
-
Utile/perdita netta:
$-91.00M
Rapporto P/E:
-23.49
EPS:
-3.67
Flusso di cassa netto:
$-74.38M
1 W Prestazione:
+0.69%
1M Prestazione:
+30.48%
6M Prestazione:
+74.46%
1 anno Prestazione:
+92.37%
Intervallo 1D:
$84.52
$87.00
Intervallo di 1 settimana:
$83.95
$89.79
Portata 52W:
$30.82
$95.95
Disc Medicine Inc Stock (IRON) Company Profile
Nome
Disc Medicine Inc
Settore
Industria
Telefono
(617) 674-9274
Indirizzo
321 ARSENAL STREET, SUITE 101, WATERTOWN
Confronta IRON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
86.22 | 3.21B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-06-11 | Ripresa | Raymond James | Strong Buy |
| 2025-02-27 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-22 | Iniziato | Wells Fargo | Overweight |
| 2024-04-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-05-17 | Iniziato | Raymond James | Outperform |
| 2023-04-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Iniziato | Stifel | Buy |
| 2023-04-20 | Iniziato | Morgan Stanley | Overweight |
| 2023-03-23 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-28 | Iniziato | SVB Securities | Outperform |
Mostra tutto
Disc Medicine Inc Borsa (IRON) Ultime notizie
Why Disc Medicine Inc. stock is considered a top pickExit Point & Entry Point Confirmation Signals - newser.com
Is Disc Medicine Inc. stock trading near support levelsQuarterly Portfolio Report & Real-Time Market Sentiment Reports - newser.com
Will Disc Medicine Inc. stock maintain growth story2025 Risk Factors & Reliable Momentum Entry Alerts - newser.com
Applying Wyckoff theory to Disc Medicine Inc. stockJuly 2025 Earnings & Capital Efficiency Focused Ideas - newser.com
Morgan Stanley Issues Positive Forecast for Disc Medicine (NASDAQ:IRON) Stock Price - MarketBeat
Disc Medicine stock reiterated Strong Buy at Raymond James on DISC-0974 potential - Investing.com
Analysts Conflicted on These Healthcare Names: Kyverna Therapeutics, Inc. (KYTX), Disc Medicine (IRON) and Baxter International (BAX) - The Globe and Mail
Disc Medicine to Participate in Upcoming Investor Conferences - Enidnews.com
Disc Medicine (NASDAQ: IRON) to appear at Guggenheim, Stifel, Jefferies; live webcasts - Stock Titan
Can Disc Medicine Inc. stock weather global recession2025 Earnings Impact & Weekly High Momentum Picks - newser.com
Is Disc Medicine Inc. stock in correction or buying zone2025 Technical Overview & Risk Controlled Swing Trade Alerts - newser.com
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
What valuation multiples suggest for Disc Medicine Inc. stockEarnings Growth Summary & Real-Time Chart Breakout Alerts - newser.com
WilmerHale Advises Underwriters in $287.5 Million Public Offering of Disc Medicine - WilmerHale
IRON Stock: Morgan Stanley Raises Price Target to $115 | IRON St - GuruFocus
Morgan Stanley Raises Price Target on Disc Medicine to $115 From $90, Keeps Overweight Rating - MarketScreener
Disc Medicine’s Promising Anemia Treatment Study: Key Insights for Investors - MSN
Chronic Kidney Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Jiangsu HengRui, Disc Medicine, 3SBio, Kind Pharma, Jiangsu Hansoh Pharm - Barchart.com
Disc Medicine (IRON): Evaluating Valuation After New Clinical Trial Plans and FDA Recognition Boost Pipeline Momentum - Yahoo Finance
Disc Medicine planning trial of iron overload treatment for sickle cell - Sickle Cell Disease News
Aug Chart Watch: Why Disc Medicine Inc. stock is considered a top pickQuarterly Earnings Summary & Daily Entry Point Trade Alerts - fcp.pa.gov.br
Top chart patterns to watch in Disc Medicine Inc.July 2025 Breakouts & Consistent Profit Focused Trading Strategies - newser.com
How Disc Medicine Inc. stock performs in interest rate cycles2025 AllTime Highs & Weekly Top Gainers Trade List - newser.com
Disc Medicine’s APOLLO Study: A Potential Game-Changer for EPP and XLP Treatment - TipRanks
Disc Medicine’s Promising Phase 2 Study on DISC-3405 for Polycythemia Vera - TipRanks
Disc Medicine’s New Study on DISC-3405: A Potential Breakthrough for Sickle Cell Disease - TipRanks
What Makes Disc Medicine, Inc. (IRON) a Strong Momentum Stock: Buy Now? - sharewise.com
Disc Medicine’s Promising EPP Treatment Study: Key Updates and Market Impact - TipRanks
Disc Medicine Inc Azioni (IRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):